Viewing Study NCT01004432


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2025-12-25 @ 7:33 PM
Study NCT ID: NCT01004432
Status: COMPLETED
Last Update Posted: 2015-04-30
First Post: 2009-10-29
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
Sponsor: Janssen Biotech, Inc.
Organization: